Financial Advocates Investment Management - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 23 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Advocates Investment Management ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,880
+21.1%
23,0970.0%0.00%
Q4 2022$2,379
-88.1%
23,0970.0%0.00%
-100.0%
Q2 2022$20,000
-31.0%
23,0970.0%0.00%0.0%
Q1 2022$29,000
-35.6%
23,0970.0%0.00%
-33.3%
Q4 2021$45,000
-28.6%
23,0970.0%0.00%
-25.0%
Q3 2021$63,000
+28.6%
23,0970.0%0.00%
+33.3%
Q1 2021$49,000
+8.9%
23,0970.0%0.00%0.0%
Q4 2020$45,000
+181.2%
23,0970.0%0.00%
+200.0%
Q3 2020$16,000
+33.3%
23,0970.0%0.00%0.0%
Q2 2020$12,000
+20.0%
23,0970.0%0.00%0.0%
Q1 2020$10,000
-37.5%
23,0970.0%0.00%
-50.0%
Q4 2019$16,000
-36.0%
23,0970.0%0.00%
-33.3%
Q3 2019$25,000
+47.1%
23,0970.0%0.00%
+50.0%
Q2 2019$17,000
-43.3%
23,0970.0%0.00%
-50.0%
Q1 2019$30,000
-14.3%
23,0970.0%0.00%
-20.0%
Q4 2018$35,000
+9.4%
23,0970.0%0.01%
+25.0%
Q2 2018$32,000
+52.4%
23,0970.0%0.00%
+33.3%
Q1 2018$21,00023,0970.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders